SERUM PSA AFTER ANTIANDROGEN THERAPY

Prostate Specific Antigen: A Critical Assessment of the Most Useful Tumor Marker for Adenocarcinoma of the Prostate

1991 • 1,273 citations

Prostate Specific Antigen in the Staging of Localized Prostate Cancer: Influence of Tumor Differentiation, Tumor Volume and Benign Hyperplasia

1990 • 625 citations

Prostatic Specific Antigen and Prostatic Acid Phosphatase in the Monitoring and Staging of Patients with Prostatic Cancer

1987 • 313 citations

Hormonal regulation of prostate-specific antigen messenger RNA in human prostatic adenocarcinoma cell line LNCaP.

1991 • 266 citations

Hormone-regulated apoptosis results from reentry of differentiated prostate cells onto a defective cell cycle.

1992 • 245 citations

Serum prostate specific antigen levels in mice bearing human prostate LNCaP tumors are determined by tumor volume and endocrine and growth factors.

1992 • 228 citations

Prostate Specific Antigen in the Diagnosis and Treatment of Adenocarcinoma of the Prostate. IV. Anti-Androgen Treated Patients

1989 • 212 citations

Estramustine and Vinblastine: Use of Prostate Specific Antigen as a Clinical Trial End Point for Hormone Refractory Prostatic Cancer

1992 • 206 citations

Use of human prostate-specific antigen in monitoring prostate cancer.

1981 • 192 citations

Orchiectomy and Nilutamide or Placebo as Treatment of Metastatic Prostatic Cancer in a Multinational Double-Blind Randomized Trial

1993 • 182 citations

Hormonal regulation of prostate‐specific antigen (PSA) glycoprotein in the human prostatic adenocarcinoma cell line, LNCaP

1992 • 179 citations

The Clinical Usefulness of Serum Prostate Specific Antigen After Hormonal Therapy of Metastatic Prostate Cancer

1992 • 175 citations

Androgens up-regulate the human prostate-specific antigen messenger ribonucleic acid (mRNA), but down-regulate the prostatic acid phosphatase mRNA in the LNCaP cell line.

1992 • 166 citations

Effect of Finasteride, a 5α-Reductase Inhibitor on Prostate Tissue Androgens and Prostate-Specific Antigen*

1990 • 136 citations

The Influence of Reversible Androgen Deprivation on Serum Prostate-Specific Antigen Levels in Men with Benign Prostatic Hyperplasia

1989 • 134 citations

Prostate Specific Antigen in Hormonally Treated Stage D2 Prostate Cancer: Is it always an Accurate Indicator of Disease Status?

1991 • 124 citations

Prognostic Significance of Prostate Specific Antigen in Endocrine Treatment for Prostatic Cancer

1990 • 124 citations

Prostatic Specific Antigen and the Prediction of Prognosis in Metastatic Prostatic Cancer

1990 • 90 citations

Androgens up-regulate the human prostate-specific antigen messenger ribonucleic acid (mRNA), but down-regulate the prostatic acid phosphatase mRNA in the LNCaP cell line

1992 • 87 citations

Criteria for Evaluating Patient Responses to Treatment Modalities for Prostatic Cancer

1984 • 86 citations

High-dose intravenous estrogen therapy in advanced prostatic carcinoma

1989 • 64 citations

Evaluation of High-Dose Cisplatin and 5-FU Infusion as Initial Therapy in Advanced Head and Neck Cancer

1988 • 48 citations

The Response of Poorly Differentiated Prostatic Tumors to Staining for Prostate Specific Antigen and Prostatic Acid Phosphatase: A Comparative Study

1987 • 45 citations

Prostate Specific Antigen and Prostatic Acid Phosphatase for Monitoring Therapy of Carcinoma of the Prostate

1991 • 44 citations

Changes in immunohistochemical staining in prostatic adenocarcinoma following diethylstilbestrol therapy

1985 • 40 citations

Prostate Specific Antigen for Assessing Response to Ketoconazole and Prednisone in Patients with Hormone Refractory Metastatic Prostate Cancer

1990 • 35 citations

Quantitative Estimation of Tissue Prostate Specific Antigen, Deoxyribonucleic Acid Ploidy and Cytological Grade in Fine Needle Aspiration Biopsies for Prognosis of Hormonally Treated Prostatic Carcinoma

1992 • 32 citations

Biochemical Monitoring of Carcinoma of Prostate Treated with an LH‐RH Analogue (Zoladex)

1986 • 31 citations

The prognostic significance of prostate specific antigen in metastatic hormone-resistant prostate cancer

1992 • 30 citations

Value of Biochemical Markers in the Management of Disseminated Prostatic Cancer

1992 • 29 citations

The Usefulness of Prostate-Specific Antigen and Prostatic Acid Phosphatase in Clinical Practice

1988 • 28 citations

Therapeutic alternatives for hormone-refractory prostatic cancer.

1992 • 23 citations

Response to second-line hormonal manipulation monitored by serum PSA in stage D2 prostate carcinoma

1992 • 22 citations

Changes in prostate-specific markers under chronic gonadotrophin-releasing hormone analogue treatment of stage D prostatic cancer

1989 • 19 citations

Deleted Work

1955 • 0 citations